413 related articles for article (PubMed ID: 33177193)
1. The Vaccinia Virus B12 Pseudokinase Represses Viral Replication via Interaction with the Cellular Kinase VRK1 and Activation of the Antiviral Effector BAF.
Rico AB; Linville AC; Olson AT; Wang Z; Wiebe MS
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177193
[TBL] [Abstract][Full Text] [Related]
2. The Vaccinia Virus (VACV) B1 and Cellular VRK2 Kinases Promote VACV Replication Factory Formation through Phosphorylation-Dependent Inhibition of VACV B12.
Rico AB; Wang Z; Olson AT; Linville AC; Bullard BL; Weaver EA; Jones C; Wiebe MS
J Virol; 2019 Oct; 93(20):. PubMed ID: 31341052
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the Vaccinia Virus B1 Kinase Reveals Essential Functions of This Enzyme Complemented Partly by the Homologous Cellular Kinase VRK2.
Olson AT; Rico AB; Wang Z; Delhon G; Wiebe MS
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515294
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Cellular VRK1, BAF, and Innate Immune Signaling by the Vaccinia Virus B12 Pseudokinase.
Linville AC; Rico AB; Teague H; Binsted LE; Smith GL; Albarnaz JD; Wiebe MS
J Virol; 2022 Jun; 96(11):e0039822. PubMed ID: 35543552
[TBL] [Abstract][Full Text] [Related]
5. A poxvirus pseudokinase represses viral DNA replication via a pathway antagonized by its paralog kinase.
Olson AT; Wang Z; Rico AB; Wiebe MS
PLoS Pathog; 2019 Feb; 15(2):e1007608. PubMed ID: 30768651
[TBL] [Abstract][Full Text] [Related]
6. Vaccinia Virus B1 Kinase Is Required for Postreplicative Stages of the Viral Life Cycle in a BAF-Independent Manner in U2OS Cells.
Jamin A; Ibrahim N; Wicklund A; Weskamp K; Wiebe MS
J Virol; 2015 Oct; 89(20):10247-59. PubMed ID: 26223647
[TBL] [Abstract][Full Text] [Related]
7. The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus.
Nichols RJ; Wiebe MS; Traktman P
Mol Biol Cell; 2006 May; 17(5):2451-64. PubMed ID: 16495336
[TBL] [Abstract][Full Text] [Related]
8. Functional disruption of the moloney murine leukemia virus preintegration complex by vaccinia-related kinases.
Suzuki Y; Ogawa K; Koyanagi Y; Suzuki Y
J Biol Chem; 2010 Jul; 285(31):24032-43. PubMed ID: 20511217
[TBL] [Abstract][Full Text] [Related]
9. Members of a novel family of mammalian protein kinases complement the DNA-negative phenotype of a vaccinia virus ts mutant defective in the B1 kinase.
Boyle KA; Traktman P
J Virol; 2004 Feb; 78(4):1992-2005. PubMed ID: 14747564
[TBL] [Abstract][Full Text] [Related]
10. Poxviral B1 kinase overcomes barrier to autointegration factor, a host defense against virus replication.
Wiebe MS; Traktman P
Cell Host Microbe; 2007 May; 1(3):187-97. PubMed ID: 18005698
[TBL] [Abstract][Full Text] [Related]
11. Barrier to autointegration factor (BAF) inhibits vaccinia virus intermediate transcription in the absence of the viral B1 kinase.
Ibrahim N; Wicklund A; Jamin A; Wiebe MS
Virology; 2013 Sep; 444(1-2):363-73. PubMed ID: 23891157
[TBL] [Abstract][Full Text] [Related]
12. Identification of two novel human putative serine/threonine kinases, VRK1 and VRK2, with structural similarity to vaccinia virus B1R kinase.
Nezu J; Oku A; Jones MH; Shimane M
Genomics; 1997 Oct; 45(2):327-31. PubMed ID: 9344656
[TBL] [Abstract][Full Text] [Related]
13. Cell- and virus-mediated regulation of the barrier-to-autointegration factor's phosphorylation state controls its DNA binding, dimerization, subcellular localization, and antipoxviral activity.
Jamin A; Wicklund A; Wiebe MS
J Virol; 2014 May; 88(10):5342-55. PubMed ID: 24600006
[TBL] [Abstract][Full Text] [Related]
14. VRK1 phosphorylates CREB and mediates CCND1 expression.
Kang TH; Park DY; Kim W; Kim KT
J Cell Sci; 2008 Sep; 121(Pt 18):3035-41. PubMed ID: 18713830
[TBL] [Abstract][Full Text] [Related]
15. Depletion of the protein kinase VRK1 disrupts nuclear envelope morphology and leads to BAF retention on mitotic chromosomes.
Molitor TP; Traktman P
Mol Biol Cell; 2014 Mar; 25(6):891-903. PubMed ID: 24430874
[TBL] [Abstract][Full Text] [Related]
16. The human vaccinia-related kinase 1 (VRK1) phosphorylates threonine-18 within the mdm-2 binding site of the p53 tumour suppressor protein.
Lopez-Borges S; Lazo PA
Oncogene; 2000 Jul; 19(32):3656-64. PubMed ID: 10951572
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of poxvirus orthologues of the vaccinia virus E3 protein: modulation of protein kinase R activity, cytokine responses, and virus pathogenicity.
Myskiw C; Arsenio J; Hammett C; van Bruggen R; Deschambault Y; Beausoleil N; Babiuk S; Cao J
J Virol; 2011 Dec; 85(23):12280-91. PubMed ID: 21917954
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibitor sensitivity between human kinases VRK1 and VRK2.
Vázquez-Cedeira M; Barcia-Sanjurjo I; Sanz-García M; Barcia R; Lazo PA
PLoS One; 2011; 6(8):e23235. PubMed ID: 21829721
[TBL] [Abstract][Full Text] [Related]
19. Characterization of three paralogous members of the Mammalian vaccinia related kinase family.
Nichols RJ; Traktman P
J Biol Chem; 2004 Feb; 279(9):7934-46. PubMed ID: 14645249
[TBL] [Abstract][Full Text] [Related]
20. Structural characterization of human Vaccinia-Related Kinases (VRK) bound to small-molecule inhibitors identifies different P-loop conformations.
Couñago RM; Allerston CK; Savitsky P; Azevedo H; Godoi PH; Wells CI; Mascarello A; de Souza Gama FH; Massirer KB; Zuercher WJ; Guimarães CRW; Gileadi O
Sci Rep; 2017 Aug; 7(1):7501. PubMed ID: 28790404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
